Myderm Pro Freeze Cooling Menthol Pain Relief Roll-on Gel
Product Images NDC 72667-073

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Myderm Pro Freeze Cooling Menthol Pain Relief Roll-on (NDC 72667-073). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Inspec Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Yaral Carton (Lidocaine Carton)

Yaral Carton (Lidocaine Carton)
Packaging label for Lidocaine Patch 5% topical patches by YARAL Pharma Inc. The label shows the product name, strength (5%), and dosage form (patch). It indicates each adhesive patch contains 700 mg lidocaine (50 mg/g), with 30 patches per package. The label includes instructions, warnings, manufacturer and distributor information, and barcodes.*
FDA Label Image

Myderm Freeze (Myderm Bottle)

Myderm Freeze (Myderm Bottle)
myDerm Professional Freeze Pain Relief Roll-On contains cooling menthol for topical use, packaged in a 2.5 fluid ounce (74 mL) roll-on bottle. The label highlights 50% more menthol for pain relief, but this product is not labeled as Lidocaine 5% or related to the provided product data from YARAL Pharma Inc.*
FDA Label Image

Relivyx Plus Packaging (Relivyx Plus Carton)

Relivyx Plus Packaging (Relivyx Plus Carton)
Packaging label for Relivyx Plus, a human prescription drug topical patch containing lidocaine 5%. The label includes the product name, NDC number 72835-555-02, Rx only status, and the manufacturer's name, V2 Pharma. The design features red and gray wavy lines on a white background.*
FDA Label Image

Graphs (Graphs)

Graphs (Graphs)
A line graph showing plasma lidocaine concentration (ng/mL) over a 72-hour period. The x-axis represents time in hours, while the y-axis shows plasma lidocaine levels. The curve depicts three peak concentration periods occurring approximately every 24 hours.*
FDA Label Image

Molecule (Molecule)

Molecule (Molecule)
Chemical structure of lidocaine, the active ingredient in Lidocaine 5% topical patch by YARAL Pharma Inc. The diagram shows the molecular formula and bonding arrangement typical of lidocaine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.